AMENDMENT NO. 1 TO DEVELOPMENT AND LICENSE AGREEMENTInsulet Corp • March 5th, 2008 • Surgical & medical instruments & apparatus
This Amendment No. 1 (the “Amendment”) dated March 3, 2008 (“Amendment Effective Date”) is entered into by and between Abbott Diabetes Care Inc., formerly known as TheraSense, Inc., (“ADC”) and Insulet Corporation (“Insulet”) to amend the Development and License Agreement entered into between TheraSense, Inc. (“Therasense”) and Insulet, effective as of January 23, 2002 (the “Agreement”). Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Agreement.
